Pilar de la Rocha Mur/LinkedIn
Jul 11, 2026, 18:53
Pilar de la Rocha Mur: Why Trust Is the Most Valuable Currency in Clinical Research
Pilar de la Rocha Mur, Vice-President, Head of EMEA at BeOne Medicines, shared on LinkedIn:
”Trust is still the real currency in clinical research.
That was the theme that ran through the BeOne Medicines investigator meeting at EHA 2026 in Stockholm, and it’s one I keep coming back to.
Last night in Stockholm, I had the privilege of being in a room with some of Europe‘s leading hematology investigators.
Around 100 experts with one shared purpose: making clinical research better for patients.
What stayed with me the most was the quality of the conversation.
Here are my two takeaways from an evening that reminded me why this work matters.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Aug 25, 2026, 19:45Cara T. Hoepner: Omega-3 is Not an Exposure
-
Aug 25, 2026, 19:42Mark Skinner Honored With the Lifetime Achievement Award – National Bleeding Disorders Foundation
-
Aug 25, 2026, 19:41Katrina Snow: Honoured to Share NYG’s Ongoing QI Work Focused on Transfusion Safety in SCD
-
Aug 25, 2026, 19:39José María López Alemany: Madrid Makes an Urgent Appeal for Blood Donation as Reserves Fall to 38%
-
Aug 25, 2026, 19:36Carlos Mirel Peñate: How Are We Actually Managing AF in ATTR-CM?
-
Aug 25, 2026, 19:35Kelly Anderson: Anticoagulation and Cognitive Health in Older Adults With AF and Alzheimer’s Disease
-
Aug 25, 2026, 19:34Uriel Suárez: Managing Anticoagulation in Patients With Brain Metastases
-
Aug 25, 2026, 19:33Ali Moradi: Excited to Present Two Abstracts at AHA 2026
-
Aug 25, 2026, 19:31Sidi Mohamed El Amine Benlazar: How Romiplostim Induces Immune Tolerance in the Treatment of ITP